FindTrial
Sign In

To study the correlation of expression of IHC marker PD-L1 with prognosis in cases of Urothelial Carcinoma of Urinary Bladder in a tertiary care hospital

Study of correlation of PD-L1 expression with prognosis in Urothelial Carcinoma of Urinary Bladder: A Hospital Based Cross-Sectional Study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/109472
Enrollment
44
Registered
2026-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N33- Bladder disorders in diseases classified elsewhere

Interventions

Intervention1: Nil: Nil

Sponsors

Najeeb Ahmed Memon
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the histopathologically diagnosed cases of UC of the Urinary Bladder that include: 1. Small, intermediate & large biopsies. 2. Resected specimens (Cystectomy) of Urothelial Carcinoma of the Urinary Bladder.

Exclusion criteria

Exclusion criteria: 1. Benign lesions of the Urinary Bladder. 2. Metastatic lesions. 3. Improperly preserved samples. 4. Inadequate samples/specimens.

Design outcomes

Primary

MeasureTime frame
To study the correlation of PD-L1 expression with prognosis in Urothelial Carcinoma of Urinary Bladder.Timepoint: Baseline—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactNajeeb Ahmed Memon

KAHERs JNMC, Belagavi

vdhorigol@gmail.com9964318734

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026